- Home
- / Legend Biotech
Legend Biotech
Stock Price
$45.5
2024-10-29
Market Capitalization
$8.4 B
2024-10-29
Revenue
$1 B
FY, 2025
Legend Biotech Summary
Company Summary
- Overview
- Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications. It also provides research and development, cell clinical studies, therapy, and other services.
- Type
- Public
- Status
- Active
- Founded
- 2014
- HQ
- Somerset, NJ, US | view all locations
- Website
- https://legendbiotech.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Lori MacOmber, Chief Financial Officer
Guowei Fang, Chief Scientific Officer and Head of Business Development
Mythili Koneru, Chief Medical Officer
LocationsView all
6 locations detected
Somerset, NJ HQ
United States
2101 Cottontail Lane
Piscataway, NJ
United States
10 Knightsbridge Road
Ghent, Vlaams Gewest
Belgium
Technologiepark 122
Nanjing
China
No. 6 Building, Life Science TechTown, 568 Longmian Avenue
Hong Kong, Hong Kong Island
Hong Kong
The Hong Kong Club Building, 3A Chater Rd
Dublin, County Dublin
Ireland
10A Ballymoss Road, Sandyford Business Park
Legend Biotech Financials
Summary Financials
- Revenue (FY, 2025)
- $1.0B
- Gross profit (FY, 2025)
- $620.8M
- Net income (FY, 2025)
- ($296.8M)
- Cash (FY, 2025)
- $901.9M
- EBIT (FY, 2025)
- ($136.5M)
- Enterprise value
- $7.9B